nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—CYP2C19—chronic kidney failure	0.696	1	CbGaD
Tapentadol—CYP2C9—cardial valve—chronic kidney failure	0.0161	0.181	CbGeAlD
Tapentadol—SLC6A2—sympathetic nervous system—chronic kidney failure	0.00869	0.0974	CbGeAlD
Tapentadol—HTR3A—nerve—chronic kidney failure	0.00489	0.0549	CbGeAlD
Tapentadol—OPRM1—nerve—chronic kidney failure	0.00449	0.0503	CbGeAlD
Tapentadol—CYP2C19—urine—chronic kidney failure	0.00448	0.0502	CbGeAlD
Tapentadol—CYP2C9—urine—chronic kidney failure	0.00347	0.0389	CbGeAlD
Tapentadol—SLC6A2—nerve—chronic kidney failure	0.00329	0.0368	CbGeAlD
Tapentadol—UGT1A9—renal system—chronic kidney failure	0.00295	0.0331	CbGeAlD
Tapentadol—UGT1A9—kidney—chronic kidney failure	0.00285	0.032	CbGeAlD
Tapentadol—SLC6A4—blood plasma—chronic kidney failure	0.00282	0.0316	CbGeAlD
Tapentadol—CYP2D6—urine—chronic kidney failure	0.00261	0.0292	CbGeAlD
Tapentadol—UGT1A9—digestive system—chronic kidney failure	0.00242	0.0271	CbGeAlD
Tapentadol—UGT2B7—renal system—chronic kidney failure	0.00238	0.0267	CbGeAlD
Tapentadol—CYP2C19—blood plasma—chronic kidney failure	0.00234	0.0262	CbGeAlD
Tapentadol—OPRD1—renal system—chronic kidney failure	0.00233	0.0261	CbGeAlD
Tapentadol—UGT2B7—kidney—chronic kidney failure	0.0023	0.0258	CbGeAlD
Tapentadol—OPRD1—kidney—chronic kidney failure	0.00226	0.0253	CbGeAlD
Tapentadol—UGT2B7—digestive system—chronic kidney failure	0.00195	0.0219	CbGeAlD
Tapentadol—CYP2C9—blood plasma—chronic kidney failure	0.00181	0.0203	CbGeAlD
Tapentadol—HTR3A—digestive system—chronic kidney failure	0.00142	0.016	CbGeAlD
Tapentadol—CYP2D6—blood plasma—chronic kidney failure	0.00136	0.0152	CbGeAlD
Tapentadol—HTR3A—blood—chronic kidney failure	0.00136	0.0152	CbGeAlD
Tapentadol—Rivastigmine—CYP3A4—chronic kidney failure	0.00135	1	CrCbGaD
Tapentadol—OPRM1—blood—chronic kidney failure	0.00124	0.0139	CbGeAlD
Tapentadol—SLC6A4—digestive system—chronic kidney failure	0.00109	0.0122	CbGeAlD
Tapentadol—SLC6A2—gonad—chronic kidney failure	0.00104	0.0117	CbGeAlD
Tapentadol—SLC6A4—blood—chronic kidney failure	0.00103	0.0116	CbGeAlD
Tapentadol—CYP2C19—digestive system—chronic kidney failure	0.000899	0.0101	CbGeAlD
Tapentadol—CYP2C19—blood—chronic kidney failure	0.000857	0.0096	CbGeAlD
Tapentadol—CYP2C9—cardiovascular system—chronic kidney failure	0.00084	0.00941	CbGeAlD
Tapentadol—CYP2C9—digestive system—chronic kidney failure	0.000697	0.00781	CbGeAlD
Tapentadol—CYP2C9—blood—chronic kidney failure	0.000664	0.00744	CbGeAlD
Tapentadol—CYP2D6—renal system—chronic kidney failure	0.000638	0.00715	CbGeAlD
Tapentadol—CYP2D6—kidney—chronic kidney failure	0.000617	0.00691	CbGeAlD
Tapentadol—CYP2D6—digestive system—chronic kidney failure	0.000523	0.00586	CbGeAlD
Tapentadol—CYP2D6—blood—chronic kidney failure	0.000498	0.00559	CbGeAlD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	4.04e-05	0.000189	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—F2—chronic kidney failure	4.04e-05	0.000189	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ACAT1—chronic kidney failure	4.04e-05	0.000189	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	4.04e-05	0.000189	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—SREBF1—chronic kidney failure	4.03e-05	0.000188	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NCF1—chronic kidney failure	4.01e-05	0.000188	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—ALB—chronic kidney failure	4e-05	0.000187	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	3.99e-05	0.000187	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NPS—chronic kidney failure	3.97e-05	0.000186	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	3.95e-05	0.000185	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—HMGCR—chronic kidney failure	3.92e-05	0.000183	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—EDN1—chronic kidney failure	3.91e-05	0.000183	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—F2—chronic kidney failure	3.9e-05	0.000183	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FGF23—chronic kidney failure	3.9e-05	0.000182	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD1—chronic kidney failure	3.89e-05	0.000182	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL5—chronic kidney failure	3.88e-05	0.000181	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	3.87e-05	0.000181	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCR5—chronic kidney failure	3.85e-05	0.00018	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—FASN—chronic kidney failure	3.83e-05	0.000179	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MLXIPL—chronic kidney failure	3.79e-05	0.000177	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HBEGF—chronic kidney failure	3.78e-05	0.000177	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CYBA—chronic kidney failure	3.77e-05	0.000176	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SLC22A2—chronic kidney failure	3.77e-05	0.000176	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	3.77e-05	0.000176	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MLXIPL—chronic kidney failure	3.76e-05	0.000176	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	3.69e-05	0.000172	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	3.68e-05	0.000172	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—POMC—chronic kidney failure	3.68e-05	0.000172	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NPY—chronic kidney failure	3.67e-05	0.000172	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CAT—chronic kidney failure	3.64e-05	0.00017	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL2—chronic kidney failure	3.6e-05	0.000168	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—POMC—chronic kidney failure	3.56e-05	0.000166	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP3A4—chronic kidney failure	3.55e-05	0.000166	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—F2—chronic kidney failure	3.55e-05	0.000166	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CRH—chronic kidney failure	3.54e-05	0.000165	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—OXT—chronic kidney failure	3.54e-05	0.000165	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ABCB1—chronic kidney failure	3.54e-05	0.000165	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	3.53e-05	0.000165	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ABCG1—chronic kidney failure	3.5e-05	0.000164	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR5—chronic kidney failure	3.49e-05	0.000163	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ABCA1—chronic kidney failure	3.49e-05	0.000163	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SLC22A2—chronic kidney failure	3.47e-05	0.000162	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SLC22A2—chronic kidney failure	3.44e-05	0.000161	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIP5K1B—chronic kidney failure	3.43e-05	0.00016	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NCF1—chronic kidney failure	3.39e-05	0.000158	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—LPL—chronic kidney failure	3.37e-05	0.000158	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ARG2—chronic kidney failure	3.36e-05	0.000157	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	3.36e-05	0.000157	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NPS—chronic kidney failure	3.36e-05	0.000157	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HBEGF—chronic kidney failure	3.31e-05	0.000155	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—F2—chronic kidney failure	3.3e-05	0.000154	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LCAT—chronic kidney failure	3.29e-05	0.000154	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD1—chronic kidney failure	3.29e-05	0.000154	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AVP—chronic kidney failure	3.27e-05	0.000153	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CYP1A1—chronic kidney failure	3.26e-05	0.000152	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—POMC—chronic kidney failure	3.23e-05	0.000151	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ABCG1—chronic kidney failure	3.22e-05	0.000151	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ABCG1—chronic kidney failure	3.19e-05	0.000149	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CYBA—chronic kidney failure	3.19e-05	0.000149	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL2—chronic kidney failure	3.16e-05	0.000148	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIP5K1B—chronic kidney failure	3.15e-05	0.000147	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIP5K1B—chronic kidney failure	3.13e-05	0.000146	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EDN1—chronic kidney failure	3.11e-05	0.000146	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL5—chronic kidney failure	3.09e-05	0.000144	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ARG2—chronic kidney failure	3.09e-05	0.000144	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ARG2—chronic kidney failure	3.06e-05	0.000143	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MTHFR—chronic kidney failure	3.03e-05	0.000142	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LCAT—chronic kidney failure	3.03e-05	0.000142	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—DDC—chronic kidney failure	3.02e-05	0.000141	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—LPL—chronic kidney failure	3.02e-05	0.000141	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—POMC—chronic kidney failure	3.01e-05	0.000141	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LCAT—chronic kidney failure	3e-05	0.00014	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—F2—chronic kidney failure	3e-05	0.00014	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARA—chronic kidney failure	2.98e-05	0.000139	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CAT—chronic kidney failure	2.95e-05	0.000138	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PRKAG2—chronic kidney failure	2.94e-05	0.000137	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PRKD1—chronic kidney failure	2.94e-05	0.000137	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP2B6—chronic kidney failure	2.94e-05	0.000137	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.89e-05	0.000135	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ABCB1—chronic kidney failure	2.87e-05	0.000134	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AVP—chronic kidney failure	2.87e-05	0.000134	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NGF—chronic kidney failure	2.86e-05	0.000134	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HBEGF—chronic kidney failure	2.8e-05	0.000131	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.79e-05	0.00013	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR5—chronic kidney failure	2.78e-05	0.00013	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—DDC—chronic kidney failure	2.78e-05	0.00013	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—DDC—chronic kidney failure	2.76e-05	0.000129	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SREBF2—chronic kidney failure	2.75e-05	0.000129	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—LPL—chronic kidney failure	2.74e-05	0.000128	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EDN1—chronic kidney failure	2.73e-05	0.000128	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—POMC—chronic kidney failure	2.73e-05	0.000128	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL5—chronic kidney failure	2.71e-05	0.000127	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP2B6—chronic kidney failure	2.7e-05	0.000126	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PRKAG2—chronic kidney failure	2.7e-05	0.000126	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PRKD1—chronic kidney failure	2.7e-05	0.000126	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PRKAG2—chronic kidney failure	2.68e-05	0.000125	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP2B6—chronic kidney failure	2.68e-05	0.000125	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PRKD1—chronic kidney failure	2.68e-05	0.000125	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL2—chronic kidney failure	2.67e-05	0.000125	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ABCC3—chronic kidney failure	2.66e-05	0.000124	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GCKR—chronic kidney failure	2.66e-05	0.000124	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—LPL—chronic kidney failure	2.65e-05	0.000124	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP1A1—chronic kidney failure	2.65e-05	0.000124	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.64e-05	0.000123	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LPIN1—chronic kidney failure	2.6e-05	0.000121	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	2.55e-05	0.000119	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LRP2—chronic kidney failure	2.55e-05	0.000119	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP2C18—chronic kidney failure	2.55e-05	0.000119	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.55e-05	0.000119	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SREBF2—chronic kidney failure	2.53e-05	0.000118	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NGF—chronic kidney failure	2.51e-05	0.000117	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SREBF2—chronic kidney failure	2.51e-05	0.000117	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MTHFR—chronic kidney failure	2.47e-05	0.000115	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ABCC3—chronic kidney failure	2.44e-05	0.000114	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GCKR—chronic kidney failure	2.44e-05	0.000114	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR5—chronic kidney failure	2.44e-05	0.000114	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—POMC—chronic kidney failure	2.43e-05	0.000113	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AVP—chronic kidney failure	2.43e-05	0.000113	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GCKR—chronic kidney failure	2.42e-05	0.000113	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ABCC3—chronic kidney failure	2.42e-05	0.000113	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARA—chronic kidney failure	2.42e-05	0.000113	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LPIN1—chronic kidney failure	2.39e-05	0.000112	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—F2—chronic kidney failure	2.39e-05	0.000112	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LPIN1—chronic kidney failure	2.37e-05	0.000111	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP2C18—chronic kidney failure	2.34e-05	0.000109	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LRP2—chronic kidney failure	2.34e-05	0.000109	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	2.33e-05	0.000109	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP2C18—chronic kidney failure	2.32e-05	0.000108	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LRP2—chronic kidney failure	2.32e-05	0.000108	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EDN1—chronic kidney failure	2.31e-05	0.000108	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL5—chronic kidney failure	2.29e-05	0.000107	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IRS1—chronic kidney failure	2.26e-05	0.000106	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LPL—chronic kidney failure	2.24e-05	0.000105	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ALB—chronic kidney failure	2.21e-05	0.000103	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—POMC—chronic kidney failure	2.18e-05	0.000102	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CPT1A—chronic kidney failure	2.16e-05	0.000101	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL2—chronic kidney failure	2.13e-05	9.95e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NGF—chronic kidney failure	2.12e-05	9.91e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—NOS3—chronic kidney failure	2.12e-05	9.89e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LIPC—chronic kidney failure	2.11e-05	9.86e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—F2—chronic kidney failure	2.09e-05	9.79e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IGF1—chronic kidney failure	2.09e-05	9.78e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	2.08e-05	9.73e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR5—chronic kidney failure	2.06e-05	9.64e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CPT1A—chronic kidney failure	1.99e-05	9.31e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SERPINE1—chronic kidney failure	1.99e-05	9.29e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IRS1—chronic kidney failure	1.98e-05	9.26e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CPT1A—chronic kidney failure	1.97e-05	9.23e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—POMC—chronic kidney failure	1.97e-05	9.22e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—KRAS—chronic kidney failure	1.97e-05	9.2e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SCARB1—chronic kidney failure	1.95e-05	9.11e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP2C19—chronic kidney failure	1.94e-05	9.07e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LIPC—chronic kidney failure	1.94e-05	9.07e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—chronic kidney failure	1.94e-05	9.05e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS1—chronic kidney failure	1.93e-05	9.02e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LIPC—chronic kidney failure	1.92e-05	8.99e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP2C19—chronic kidney failure	1.92e-05	8.99e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—POMC—chronic kidney failure	1.91e-05	8.92e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.9e-05	8.87e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOS3—chronic kidney failure	1.9e-05	8.87e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.9e-05	8.87e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SREBF1—chronic kidney failure	1.89e-05	8.84e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL2—chronic kidney failure	1.87e-05	8.73e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—HMGCR—chronic kidney failure	1.84e-05	8.6e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IGF1—chronic kidney failure	1.84e-05	8.58e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—FASN—chronic kidney failure	1.8e-05	8.42e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ALB—chronic kidney failure	1.8e-05	8.4e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SCARB1—chronic kidney failure	1.79e-05	8.38e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RELA—chronic kidney failure	1.79e-05	8.35e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SCARB1—chronic kidney failure	1.78e-05	8.31e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS1—chronic kidney failure	1.77e-05	8.29e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—F2—chronic kidney failure	1.77e-05	8.27e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS1—chronic kidney failure	1.76e-05	8.22e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SERPINE1—chronic kidney failure	1.74e-05	8.15e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SREBF1—chronic kidney failure	1.74e-05	8.13e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.73e-05	8.09e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—KRAS—chronic kidney failure	1.73e-05	8.06e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SREBF1—chronic kidney failure	1.73e-05	8.06e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NOS3—chronic kidney failure	1.72e-05	8.04e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—HMGCR—chronic kidney failure	1.69e-05	7.91e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—HMGCR—chronic kidney failure	1.68e-05	7.84e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IRS1—chronic kidney failure	1.67e-05	7.83e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP3A4—chronic kidney failure	1.67e-05	7.8e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOS3—chronic kidney failure	1.66e-05	7.78e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.66e-05	7.76e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—FASN—chronic kidney failure	1.66e-05	7.74e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—FASN—chronic kidney failure	1.64e-05	7.68e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ABCA1—chronic kidney failure	1.64e-05	7.67e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—POMC—chronic kidney failure	1.61e-05	7.54e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—chronic kidney failure	1.6e-05	7.48e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL2—chronic kidney failure	1.58e-05	7.37e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—chronic kidney failure	1.57e-05	7.35e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RELA—chronic kidney failure	1.57e-05	7.32e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IGF1—chronic kidney failure	1.55e-05	7.25e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	1.53e-05	7.17e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP3A4—chronic kidney failure	1.52e-05	7.11e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.51e-05	7.08e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ABCA1—chronic kidney failure	1.51e-05	7.05e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NFKB1—chronic kidney failure	1.51e-05	7.04e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ABCA1—chronic kidney failure	1.5e-05	6.99e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SERPINE1—chronic kidney failure	1.47e-05	6.89e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—KRAS—chronic kidney failure	1.46e-05	6.82e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOS3—chronic kidney failure	1.41e-05	6.57e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—chronic kidney failure	1.4e-05	6.56e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CAT—chronic kidney failure	1.39e-05	6.49e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VEGFA—chronic kidney failure	1.37e-05	6.39e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ABCB1—chronic kidney failure	1.35e-05	6.31e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RELA—chronic kidney failure	1.32e-05	6.19e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NFKB1—chronic kidney failure	1.32e-05	6.17e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LPL—chronic kidney failure	1.29e-05	6.02e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CAT—chronic kidney failure	1.28e-05	5.97e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CAT—chronic kidney failure	1.27e-05	5.92e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TGFB1—chronic kidney failure	1.25e-05	5.87e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP1A1—chronic kidney failure	1.24e-05	5.81e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ABCB1—chronic kidney failure	1.24e-05	5.81e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ABCB1—chronic kidney failure	1.23e-05	5.76e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VEGFA—chronic kidney failure	1.2e-05	5.6e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—chronic kidney failure	1.19e-05	5.54e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LPL—chronic kidney failure	1.18e-05	5.53e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LPL—chronic kidney failure	1.17e-05	5.49e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—KRAS—chronic kidney failure	1.16e-05	5.43e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MTHFR—chronic kidney failure	1.16e-05	5.42e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	1.14e-05	5.34e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARA—chronic kidney failure	1.14e-05	5.31e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP1A1—chronic kidney failure	1.13e-05	5.3e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NFKB1—chronic kidney failure	1.12e-05	5.22e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TGFB1—chronic kidney failure	1.1e-05	5.14e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MTHFR—chronic kidney failure	1.07e-05	4.98e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MTHFR—chronic kidney failure	1.06e-05	4.94e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARA—chronic kidney failure	1.05e-05	4.89e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARA—chronic kidney failure	1.04e-05	4.85e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—KRAS—chronic kidney failure	1.02e-05	4.76e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VEGFA—chronic kidney failure	1.01e-05	4.74e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—chronic kidney failure	9.46e-06	4.42e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TGFB1—chronic kidney failure	9.3e-06	4.35e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—POMC—chronic kidney failure	9.27e-06	4.33e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—KRAS—chronic kidney failure	8.61e-06	4.03e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—POMC—chronic kidney failure	8.53e-06	3.98e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—POMC—chronic kidney failure	8.45e-06	3.95e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALB—chronic kidney failure	8.45e-06	3.95e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—chronic kidney failure	8.29e-06	3.88e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NOS3—chronic kidney failure	8.08e-06	3.78e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALB—chronic kidney failure	7.77e-06	3.63e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALB—chronic kidney failure	7.71e-06	3.6e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NOS3—chronic kidney failure	7.43e-06	3.48e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—chronic kidney failure	7.39e-06	3.46e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NOS3—chronic kidney failure	7.37e-06	3.45e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—chronic kidney failure	7.01e-06	3.28e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—chronic kidney failure	6.8e-06	3.18e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—chronic kidney failure	6.74e-06	3.15e-05	CbGpPWpGaD
